Who Mounjaro Is Best For Mounjaro tends to be especially effective for individuals who: Have type 2 diabetes or significant insulin resistance Experience strong cravings for sugars or refined carbohydrates Struggle with portion control despite sincere efforts Have metabolic syndrome or elevated A1C levels Prefer a once-weekly medication with powerful metabolic effects Have not achieved adequate results with GLP-1-only therapies Need a strong appetite and craving regulator to support long-term goals Mounjaro may also be used in the preoperative phase for bariatric surgery candidates with diabetes, helping reduce surgical risk and stabilize blood glucose before the procedure
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Regulatory approvals differ by age: liraglutide and semaglutide are approved for adolescent obesity ( 12 years) in multiple jurisdictions, but their use in younger children represents off-label prescribing
52 The effect of semaglutide on HRQoL in HFpEF, particularly social and physical function as measured by the KCCQ, is mediated at least in part by the effect on weight reduction
The complaint says these omissions inflated Hims stock price, hiding a looming regulatory collapse
